In a market where concentration risk is a growing concern, investors are constantly looking for alternative investment strategies that offer more diversification. One such approach is value-oriented investments, as suggested by Avantis Investors chief investment strategist Phil McInnis. His firm’s exchange-traded fund strategy aims to provide better returns in the long run by emphasizing companies
0 Comments
Recent research has suggested a possible link between our body’s circadian clock and the effectiveness of certain cancer treatments. Checkpoint inhibitors, which are immunotherapy drugs used to block proteins from binding to cancerous tumors, have shown promise in treating various types of cancers. However, scientists are exploring ways to enhance the impact of these drugs,
0 Comments
Princess Kate of Wales recently provided an update on her ongoing battle with cancer, stating that she still has “a few more months” of treatment ahead of her. Despite facing challenging days, she mentioned that she is making progress and remains committed to attending public engagements, including the upcoming King’s birthday parade in London. In
0 Comments
Boeing’s Starliner capsule, named “Calypso,” has recently been announced to remain at the International Space Station for a longer duration than originally planned by NASA. Initially scheduled for a nine-day mission, Calypso is now expected to return to Earth on June 22, approximately 17 days after its launch. This extension allows for further spacecraft testing,
0 Comments
Advancements in the field of oncology have paved the way for innovative treatment options for patients with non-small cell lung cancer (NSCLC). In a recent phase II study conducted in collaboration with UT Southwestern, patients with EGFR-mutant NSCLC were treated with osimertinib alone or in combination with stereotactic ablative radiation therapy (SABR). The study aimed
0 Comments